Colby Stong

A study was conducted to determine the effect of history of cardiovascular conditions on severity of COVID-19 infection in pediatric patients.

Investigators sought to develop and validate the COVID-HEART predictor to determine risk for adverse events in patients hospitalized with COVID-19.

Researchers evaluated the occurrence of adverse events following COVID-19 vaccination with mRNA- and vector-based vaccines, inactivated vaccines, DNA vaccines, and protein subunit vaccines.

Investigators examined the prevalence, clinical impact, and associations of pericardial involvement in patients hospitalized for treatment for COVID-19.

Researchers assessed independent predictors of all-cause mortality within a 2-year period among adult patients admitted to an emergency department with suspected bacterial infections.

The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.

Insurance coverage for topical treatments for rosacea vs melasma are investigated.